MedTrace Logo

Optimizing Fibromyalgia Self-management

NCT00321659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2017-03-14

No results posted yet for this study

Summary

The overall objective of this work is to improve treatment outcomes for persons with fibromyalgia by optimizing the approach to self-management. The purpose of this research project is to evaluate and compare, in a randomized, controlled trial involving 200 women, the short and long-term effectiveness of four approaches to fibromyalgia self-management for improving health and functional status, self-efficacy, and symptom severity. Additionally, we will also examine the effect of each intervention on health care usage. We will assess the following 16-week interventions:

* cardiovascular and flexibility exercise
* strength training, cardiovascular and flexibility exercise
* Arthritis Foundation's Fibromyalgia Self-Help course
* a combination of the Fibromyalgia Self-Help Course and strength training exercise interventions

Conditions

  • Fibromyalgia

Interventions

BEHAVIORAL

Aerobic

3x/week of walking and cycling

BEHAVIORAL

Strength training

3x/week of resistance training activities

BEHAVIORAL

Combination

3x/week of aerobic and strength training activities

BEHAVIORAL

FSHC

Biweekly group education group meetings

Sponsors & Collaborators

  • Arthritis Foundation

    collaborator OTHER

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Beth Israel Deaconess Medical Center

    lead OTHER

Principal Investigators

  • Daniel S. Rooks, PhD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-10
Primary Completion
2005-09-21
Completion
2005-09-21

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00321659 on ClinicalTrials.gov